Ivermectin Used for The Prevention and Treatment of COVID-19
There is new evidence supporting the use of Ivermectin in the prevention and treatment of COVID-19. There have been multiple studies recently published showing the drug Ivermectin to be effective in the prevention and treatment of COVID-19. Ivermectin has been studied in the laboratory setting and in human trials. Ivermectin was found to be an inhibitor of the SARS-CoV-2 replication in the lab. Ivermectin has also shown to be effective for the treatment of early onset Covid-19 and in viral clearance. It has been shown to inhibit the SARS virus and prevents it from multiplying.
Tried and True Medication
Ivermectin has been approved for over 40 years to treat parasitic infections and has been used safely by over 3.7 billion people. It has been shown to stop the replication of many viruses as well as being used as a prophylaxis (prevention) protocol for health care workers against the Sars-CoV 2 virus.
Prevention Protocol for COVID-19
The FLCCC Alliance (Front Line Covid-19 Critical Care Alliance) has published a prevention protocol for high-risk individuals.
- Ivermectin given at 0.2mg/kg on day 1 and day 3, then once a week for 10 weeks, then once every 2 weeks.
- Vitamin D3 1,000 to 3,000 IU/day
- Vitamin C 1000mg twice a day
- Quercetin 250mg a day
- Zinc 50mg a day
- Melatonin 6mg at bedtime
A Post Covid-19 Exposure prevention protocol of 0.2mg/kg on Day 1 and Day 3. Several treatment protocols have also been published – one with a dose of 12mg Ivermectin per day for 5 days. Another study published a one-time dose of 0.4mg/kg.
Ivermectin should not be taken if a patient has liver disease or asthma. It is contraindicated in pregnancy and breast feeding. Patients on any kind of blood thinners or any other medications should be evaluated carefully first.
For specific dosing questions, please contact our pharmacists at 817-274-0050 or schedule an appointment with your primary physician.
